FDA approves Merck s Winrevair | Drug Store News drugstorenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from drugstorenews.com Daily Mail and Mail on Sunday newspapers.
FDA Approves Merck s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) merck.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from merck.com Daily Mail and Mail on Sunday newspapers.
WINREVAIR on top of background therapy significantly improved exercise capacity and multiple important secondary outcome measures compared to background therapy alone
Merck & Co. shares soared to a record high Wednesday, a day after the Food and Drug Administration approved the drug maker's treatment for a rare cardiovascular disease.